The detection of kratom use in standard drug screenings is not typical. A standard five-panel drug test is designed to identify the presence of commonly abused substances such as amphetamines, cocaine, opiates, phencyclidine (PCP), and tetrahydrocannabinol (THC). Kratom and its metabolites are generally not included in this standard panel.
The increasing prevalence of kratom use and concerns about its potential for misuse have led to discussions regarding the need for specific kratom drug testing. While not routinely implemented, the ability to test for kratom alkaloids, such as mitragynine, does exist. This specialized testing often requires a separate request and may not be included in standard workplace or clinical drug screening protocols. The development and implementation of such tests reflect an evolving understanding of substance use patterns and related health implications.